Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122821
Filing Date
2024-11-07
Accepted
2024-11-07 08:02:48
Documents
54
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pepg-20240930.htm   iXBRL 10-Q 2099798
2 EX-10.1 pepg-ex10_1.htm EX-10.1 249270
3 EX-10.2 pepg-ex10_2.htm EX-10.2 139581
4 EX-31.1 pepg-ex31_1.htm EX-31.1 19204
5 EX-31.2 pepg-ex31_2.htm EX-31.2 18194
6 EX-32.1 pepg-ex32_1.htm EX-32.1 7991
7 EX-32.2 pepg-ex32_2.htm EX-32.2 8022
  Complete submission text file 0000950170-24-122821.txt   6708238

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20240930.xsd EX-101.SCH 873085
56 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20240930_htm.xml XML 731020
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 241433285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)